Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 21Insulin Resistance 5Obesity 4Neoplasms 3Prostatic Neoplasms 2Motor Activity 2Menstruation Disturbances 2Medulloblastoma 2Infertility 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Toxemia 1Thyroid Neoplasms 1Premature Birth 1Pregnancy Complications 1Prediabetic State 1Pre-Eclampsia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasm Metastasis 1Mouth Neoplasms 1Metabolic Syndrome 1Liver Neoplasms 1Infertility, Female 1Hyperinsulinism 1Hyperandrogenism 1

Interventions

Cholecalciferol 2Metformin 1Calcium Carbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Vitamin D Deficiency × Metformin × Clear all
NCT03792984 2019-06-06

The Effect of Calcium and Vitamin D Supplements on Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Patients

Damascus University

Phase 3 Completed
40 enrolled

Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡